TherapeuticsMD Forms Death Cross, Signaling Potential Bearish Trend Ahead
TherapeuticsMD, Inc. has recently encountered a technical event known as a Death Cross, indicating potential bearish trends. While the stock has shown short-term resilience, its longer-term performance raises concerns, with a significant decline over the past year compared to broader market gains, suggesting caution for investors.
TherapeuticsMD, Inc., a microcap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a significant technical event known as a Death Cross. This occurs when a stock's short-term moving average crosses below its long-term moving average, often signaling a potential shift in market sentiment and a bearish trend. Currently, the stock's daily moving averages are bearish, aligning with the broader technical indicators that suggest a challenging environment. The MACD is bearish on a weekly basis, while the Bollinger Bands also reflect a bearish stance. Despite these indicators, TherapeuticsMD has shown some resilience with a 1-day performance increase of 0.93%, outperforming the S&P 500, which declined by 0.55%.
However, the company's longer-term performance remains concerning, with a staggering 1-year decline of 35.33% compared to the S&P 500's gain of 16.41%. The stock's year-to-date performance of 25.58% does provide a glimmer of hope, but the overall trend suggests that investors should remain cautious. The implications of the Death Cross could indicate further volatility ahead, as market participants assess the company's position in a competitive industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
